Enter your email address

Go
You have been subscribed.

Healthcare & Life Sciences

Drew & Napier has an award-winning, multi-disciplinary Healthcare & Life Sciences Practice, with expertise in intellectual property, dispute resolution, commercial and transactional, as well as regulatory practices.

Our clients include pharmaceutical and biotechnology companies, medical devices manufacturers and governmental agencies.

Drew & Napier is the first Singaporean law firm to be recognized by Asian-Counsel Representing Corporate Asia 2010 as Life Sciences Firm of the Year.

Practice Areas  

Dispute Resolution

We are at the forefront of life sciences intellectual property disputes in Singapore. We have successfully represented the world-famous Institut Pasteur, Sanofi and Biorad in enforcing the patent for the HIV-2 virus and diagnostic kits to detect the HIV-2 virus in a ground breaking patent case in Singapore. The Singapore Court of Appeal ruled in favour of the patent owners and dismissed the appeals (See the reported decisions at Institut Pasteur & Anor v Genelabs Diagnostics Pte Ltd & Anor [2000] SGHC 53 and Genelabs Diagnostics Pte Ltd v Institut Pasteur and Another [2001] 1 SLR 121).

We have also successfully represented Novartis AG and Novartis (Singapore) Pte Ltd (“Novartis”) in their application to amend a Patent, post-grant, under section 83 of the Singapore Patents Act. This application to amend was made after Novartis started a suit for patent infringement against Ranbaxy (Malaysia) Sdn Bhd. This is the first reported Singapore case in which the hearing for the patent amendment was heard separately from the main infringement and invalidation hearing. The Singapore High Court found that the proposed amendments did not “add matter” to the Patent, and also that there was no undue delay on the part of Novartis in applying to amend the Patent in Singapore and granted the amendment. (See the reported decision at Novartis AG and Novartis (Singapore) Pte Ltd v Ranbaxy (Malaysia) Sdn Bhd [2012] SGHC 253).

The Practice also currently represents:

  • Novartis in Suit 150/2011/R and 1085/2012/G in a patent infringement action involving an invention relating to drugs for treatment of high blood pressure

  • sanofi aventis in Suit 305/2010/Y for alleged infringement of patents in the treatment of breast cancer

  • Baxter Healthcare in Suit 901/2008/B involving allegations of product liability concerning haemodialysis machines

  • sanofi aventis in Originating Summons No. 991/2011/L for a determination under Section 16(1B)(c) of the Medicines Act (Cap 176) on issues concerning patent declarations by a generic company

Corporate Commercial and Regulatory

The Practice has expertise and strength in all corporate, commercial and regulatory matters. We have advised many pharmaceutical, life sciences, biotechnology, health care, and food and beverage companies.

These include:

  • Advising on labelling, advertising, as well as sales and promotion regulations for the pharmaceutical, medical devices, and the food and beverage industries

  • Advised a healthcare institution in relation to compliance with medical laws and regulations on promotional programmes

  • Reviewing and drafting clinical trial agreements, research and development agreements, licensing agreements, franchise agreements, funding agreements

  • Advising on all aspects of employments and other regulatory matters, including employment agreements, secondment arrangements, and termination of employees

  • Assisting in the due diligence, negotiations and acquisitions of pharmaceutical products and companies, hospitals and health care institutions.

Accolades

Who’s Who Legal
Recommended individuals
Life Sciences 2015
Tony Yeo
Benjamin Gaw

Asian-Counsel – Representing Corporate Asia Survey
Life Sciences 2010 – First Singaporean firm  to be awarded Firm of the Year

Practical Law Company Which Lawyer?
Life Sciences 2011/2012 – Recommended firm for 5 consecutive years

Endorsed individuals
Life Sciences 2011/2012
Tony Yeo
Benjamin Gaw

Chambers Asia-Pacific
Intellectual Property 2016 - Band 1 for 9 consecutive years

Senior Statesman:
Morris John

Leading Individuals:      
Dedar Singh Gill
Tony Yeo

Consultant Morris John is an important member of the IP group. He assists clients with complex IP disputes and patent registration.

The “knowledgeable and practical” Dedar Singh Gill leads the firm’s IP group, and is unanimously identified as a leading IP litigator. He earns considerable praise for his technical abilities and client management skills.

Tony Yeo, who leverages on his strong healthcare and life sciences sector expertise, is described as "a very experienced and great team player.”   

“The team is very responsive, knowledgeable and hard-working. Their grasp of details is impressive.”

“They are a very strong team, especially when it comes to contentious IP work.”

The Asia Pacific Legal 500
Intellectual Property 2015/2016 – Tier 1 for 17 consecutive years

Leading Individuals:
Dedar Singh Gill
Tony Yeo

"[Dedar] is analytical, methodical, and thinks outside the box."

“[Cecelia] is flexible in responding to clients’ needs.”

 “[Tony] is excellent and experienced.”

 “[Gerald Koh] is knowledgeable and responsive.”

“Drew & Napier is the best there is when it comes to litigation.”

Managing Intellectual Property
World IP Survey 2016: Singapore – Leading IP firm for 17 consecutive years

Singapore Contentious IP Firm of the Year 2014 - 2016 

Singapore IP Firm of the Year 2013

Patent Prosecution – Tier 1
Patent Contentious – Tier 1
Trade mark Prosecution – Tier 1
Trade mark Contentious – Tier 1
Copyright – Tier 1

Asia IP Survey
Singapore Trade Mark Firm of the Year 2015 – 5 consecutive years

Copyright – Tier 1
Patent Prosecution – Tier 1
Patent Contentious – Tier 1
Trade mark Prosecution – Tier 1
Trade mark Contentious – Tier 1

Asia IP Experts 2015 Endorsed Individuals:

Tony Yeo – Pharma & Biotech, enforcement, patents and litigation
Benjamin Gaw – Pharam & Biotech